Analyst consensus rating
Chemed Analyst Rating: Buy
Direct answer
Chemed's consensus rating is Buy.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $617.00.
Forecast evidence checked November 10, 2026.
Get free Chemed email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $544.52
- Average price target
- $617.00
- High price target
- $675.00
- Low price target
- $580.00
- Low target gap
- +6.5%
- Target upside
- +13.3%
- High target gap
- +24%
- Target range width
- 17.4%
- Consensus rating
- Buy
- Analysts
- 5
- Evidence date
- November 10, 2026
- Valid through
- November 17, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Chemed?
Chemed has a verified Buy consensus. The same dataset has an average price target of $617.00.
How far are Chemed's low and high targets from the recorded price?
The low target implies +6.5%, while the high target implies +24%.
How many analysts are included in Chemed's consensus?
The verified consensus includes 5 analysts.
How is Chemed's target upside or downside calculated?
The average target of $617.00 is divided by the recorded price of $544.52, then one is subtracted to produce +13.3%. This does not guarantee a future return.
When was Chemed's analyst forecast verified?
The data was verified on 2026-11-10. The dataset is valid through 2026-11-17.